| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |